Reduced MEOX2 expression has been shown to be significantly correlated with short OS in hepatocellular and larynx carcinoma, whereas in lung cancer, MEOX2 overexpression has been demonstrated to be correlated with chemoresistance [64]. The gene discussed is MEOX2; the disease is lung cancer.